GHIT Fund commits JPY 1.06bn to nine disease R&D projects
TOKYO – October 29, 2026 -- The Global Health Innovative Technology (GHIT) Fund has committed about JPY 1.06 billion (USD 6.8 million) to nine R&D projects covering drugs, vaccines and diagnostics for malaria, neglected tropical diseases (NTDs) and emerging infectious diseases such as Ebola.
Trachoma rapid test receives JPY 450 million for clinical validation and launch
The largest single award, about JPY 450 million (USD 2.9 million), goes to a point-of-care rapid diagnostic test for trachoma. The project is led by Drugs and Diagnostics for Tropical Diseases, Medical & Biological Laboratories (MBL), The Carter Center and Big Eye Diagnostics, and has received GHIT support since 2024.